NEW YORK, Oct. 12 /PRNewswire-FirstCall/ -- On October 5, Scott Sand, CEO of Ingen Technologies, Inc. (Pink Sheets: IGTG) (http://www.ingen-tech.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones for which investors should watch.
To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or by entering the company's ticker symbol in the Search Archive window.
About Ingen Technologies:
Ingen Technologies, Inc., a Georgia Corporation, is a medical device manufacturer and a publicly traded company trading under Nasdaq OTC: IGTG, which has been in business since 1999. With FDA issued products, and a certified manufacturer with the Department of Health Services as a medical device manufacturer, the company markets proprietary products and markets cutting-edge medical technologies designed to increase accuracy of medical care and prevent unnecessary medical costs associated with today's healthcare industry. Ingen owns a variety of intellectual biotech property including several US patent(s) and several Foreign Patent(s) either issued or pending in the US, Japan, European Communities and People's Republic of China.
About WallSt.net:
http://www.wallst.net is owned and operated by WallStreet Direct, Inc.,
a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a
leading provider of timely business news, executive interviews, multimedia
c
'/>"/>
| SOURCE Financial Filings Corp. Copyright©2007 PR Newswire. All rights reserved |